AXSOME THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AXSOME THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2019-09-30 was $20.10M.
- AXSOME THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2019-06-30 was $20.10M.
- AXSOME THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2017 was $316.72K, a 858.88% increase from fiscal 2016.
- AXSOME THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2016 was $33.03K, a 99.93% decline from fiscal 2015.
- AXSOME THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2015 was $45.51M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2019-09-30 | $20.10M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $20.10M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $316.72K 10-K · filed 2019-03-15 | |
| 2016-12-31 | $33.03K 10-K · filed 2019-03-15 | |
| 2015-12-31 | $45.51M 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |